QURE
uniQure N.V.NASDAQHealthcare$17.16+1.60%ClosedMarket Cap: $1.06B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
5.03
P/S
66.55
EV/EBITDA
-10.73
DCF Value
$-8.06
FCF Yield
-16.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
71.1%
Operating Margin
-1157.9%
Net Margin
-1236.0%
ROE
-174.0%
ROA
-24.1%
ROIC
-24.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $5.6M | 38.8% | $-52.2M | $-37.1M | $-0.59 | — |
| FY 2025 | $16.1M | -2.2% | $-185.5M | $-199.0M | $-3.46 | — |
| Q3 2025 | $3.7M | 89.2% | $-51.0M | $-80.5M | $-1.38 | — |
| Q2 2025 | $5.3M | 87.5% | $-43.9M | $-37.7M | $-0.69 | — |
| Q1 2025 | $1.6M | 87.4% | $-39.3M | $-43.6M | $-0.82 | — |
| Q4 2024 | $5.2M | 88.1% | $-45.8M | $-73.3M | $-1.50 | — |
| FY 2024 | $27.1M | 32.4% | $-184.3M | $-239.6M | $-4.92 | — |
| Q3 2024 | $2.3M | 55.4% | $-40.2M | $-44.4M | $-0.91 | — |
| Q2 2024 | $11.1M | 32.9% | $-44.0M | $-56.3M | $-1.16 | — |
| Q1 2024 | $8.5M | -8.7% | $-54.2M | $-65.6M | $-1.36 | — |
| Q4 2023 | $6.7M | -32.1% | $-61.7M | $-73.2M | $-1.53 | — |
| FY 2023 | $15.8M | 14.0% | $-282.9M | $-308.5M | $-6.47 | — |